Correction of hepatosteatosis in humanized liver animals through restoration of il6/il6r/gp130 signaling in human hepatocytes
US-2024130341-A1 · Apr 25, 2024 · US
US9474254B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9474254-B2 |
| Application number | US-201414286468-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 23, 2014 |
| Priority date | Dec 1, 2008 |
| Publication date | Oct 25, 2016 |
| Grant date | Oct 25, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A spermatogonial stem cell line that is derived from testes of rats characterized by a desirable genetic background can serve as a source for cells to transplant into male-sterile recipient animals that are immuno-compatible with the spermatogonial line. Rat cells thus transplanted readily develop into fertilization-competent, haploid male gametes, with little or no endogenous sperm competition generated by the testes of the male-sterile recipient. This approach, constituting the first vector system for the use of rat spermatogonial lines from in vitro culture in generating mutant rats on a desired genetic background, effects maximal germline transmission of donor haplotypes from the transplanted spermatogonial cells.
Opening claim text (preview).
What is claimed is: 1. A method of introducing a transgene or a mutation into the genome of a male rat wherein said male rat is DAZL-deficient, comprising: a) providing a cultured rat spermatogonial stem cell line of a predetermined genetic background; (b) genetically modifying the rat spermatogonial stem cell line by gene-trap insertion mutagenesis with a transposon plasmid containing a gene-trap selection cassette comprising transposase binding sites necessary for transposition to generate a rat donor haplotype, wherein a transposon insertion site can be remobilized by the expression of a transposase recognizing the transposase binding sites in the stem cell line in culture or at a later stage in vivo; (c) transplanting the genetically modified rat spermatogonial stem cell line of a predetermined genetic background into a testicle of the male rat; and (d) allowing a time sufficient for the genetically modified rat spermatogonial stem cell line to develop into fertilization-competent, haploid male gametes, wherein DAZL-deficient rats transmitted the rat donor haplotype more efficiently than from wildtype rat recipient testes. 2. The method of claims 1 , wherein the male rat expresses a small hairpin RNA transgene that degrades DAZL mRNA. 3. The method of claims 1 , wherein the predetermined genetic background is Sprague Dawley. 4. The method of claims 1 , wherein the predetermined genetic background is Fisher 344. 5. The method of claims 1 , wherein the donor haplotype comprises an internal tandem repeat (ITR) from a transposon. 6. The method of claims 1 , wherein the donor haplotype comprises at least two fragments of a transposon sequence comprising the nucleotides of SEQ ID NO:3 and SEQ ID NO:4; CCCTAGAAAGATAGTCTGCGTAAAATTGACGCATGCATTCTTGAAATATT GCTCTCTCTTTCTAAATAGCGCGAATCCGTCGCTGTGCATTTAGGACATC TCAGTCGCCGCTTGGAGCTCCCGTGAGGCGTGCTTGTCAATGCGGTAAGT GTCACTGATTTTGAACTATAACGACCGCGTGAGTCAAAATGACGCATGAT TATCTTTTACGTGACTTTTAAGATTTAACTCATACGATAATTATATTGTT ATTTCATGTTCTACTTACGTGATAACTTATTATATATATATTTTCTTGTT ATAGATATC(SEQ ID NO: 3) and TAAAAGTTTTGTTACTTTATAGAAGAAATTTTGAGTTTTTGTTTTTTTTT AATAAATAAATAAACATAAATAAATTGTTTGTTGAATTTATTATTAGTAT GTAAGTGTAAATATAATAAAACTTAATATCTATTCAAATTAATAAATAAA CCTCGATATACAGACCGATAAAACACATGCGTCAATTTTACGCATGATTA TCTTTAACGTACGTCACAA the nucleotides of SEQ ID NO: 3 and SEQ ID NO: 4 wherein the fragments flank a mutated genetic sequence of interest. 7. The method of claims 1 , wherein the donor haplotype comprises the nucleotides of SEQ ID NO:5 and SEQ ID NO:6; CCCTAGAAAGATAGTCTGCGTAAAATTGACGCATG and CATGCGTCAATTTTACGCATGATTATCTTTAACGTACGTCACAA TATGATTAT the nucleotides of SEQ ID NO: 5 and SEQ ID NO: 6 wherein the fragments flank a mutated genetic sequence of interest. 8. The method of claims 1 , wherein the donor haplotype comprises a fragment of a transposon sequence consisting of the PiggyBac 5′ ITR and the PiggyBac 3′ ITR. 9. The method of claims 1 , wherein the donor haplotype comprises a fragment of a transposon sequence consisting of the Sleeping Beauty 5′ ITR and the Sleeping Beauty 3′ ITR. 10. A method of restoring male fertility to a DAZL-deficient rat, comprising the steps of: (a) culturing an isolated rat spermatogonial stem cell line of a predetermined genetic background; (b) genetically modifying the rat spermatogonial stem cell line by gene-trap insertion mutagenesis with a transposon plasmid containing a gene-trap selection cassette and a helper plasmid encoding a transposase to generate a rat donor haplotype; (c) transplanting the rat spermatogonial stem cell line of a predetermined genetic background into the a testicle of the male DAZL-deficient rat; wherein the genome of the modified rat spermatogonial stem cell line comprises a transposon sequence or a fragment thereof; and (d) allowing a time sufficient for the genetically modified rat spermatogonial stem cell line to develop into fertilization-competent, haploid male gametes. 11. The method of claims 10 , wherein the male rat expresses a small hairpin RNA transgene that degrades DAZL mRNA. 12. The method of claims 10 , wherein the predetermined genetic background is Sprague Dawley. 13. The method of claims 10 , wherein the predetermined genetic background is Fisher 344. 14. The method of claims 10 , wherein the donor haplotype comprises an internal tandem repeat (ITR) from a transposon. 15. The method of claims 10 , wherein the donor haplotype comprises the nucleotides of SEQ ID NO:5 and SEQ ID NO:6; wherein the fragments flank a mutated genetic sequence of interest. 16. The method of claims 10 , wherein the donor haplotype comprises the nucleotides of SEQ ID NO:5 and SEQ ID NO:6; wherein the fragments flank a mutated genetic sequence of interest. 17. The method of claims 10 , wherein the donor haplotype comprises a fragment of a transposon sequence consisting of the PiggyBac 5′ ITR and the PiggyBac 3′ ITR. 18. The method of claims 10 , wherein the donor haplotype comprises a fragment of a transposon sequence consisting of the Sleeping Beauty 5′ ITR and the Sleeping Beauty 3′ ITR.
Chimeric vertebrates, e.g. comprising exogenous cells · CPC title
Vectors containing a transposable element · CPC title
Basic fibroblast growth factor (bFGF, FGF-2) · CPC title
Thiols, e.g. mercaptoethanol · CPC title
Animals genetically altered by homologous recombination · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.